Middle East Fertility Society Journal
Middle East Fertility Society
Vol. 12, No. 1, 2007, pp. 47-52
Bioline Code: mf07008
Full paper language: English
Document type: Research Article
Document available free of charge
Middle East Fertility Society Journal, Vol. 12, No. 1, 2007, pp. 47-52
© Copyright 2007 - Middle East Fertility Society
Pharmacological effects of low- dose of aspirin on ovulation rate in mature cycling female mice|
Al-Janabi, Adnan S.; Al-Zohyri, Ahmad M. & Al-Rubayai, Fouad K.
Objective: To determine the effects of low-dose of aspirin on ovarian response, uterine and ovarian blood flow supply, and ovulation rate in mature cycling female mice.
Design: Mature cycling female mice treated with aspirin on the first day of proestrous phase.
Setting: Institute of the Embryo Research and Infertility Treatment- University of Baghdad.
Materials and methods: Mature cycling female mice treated subcutaneously twice/day with Aspirin (7.5mg/Kg.b.w)on the first day of proestrous phase. In the treated six groups (6 mice/ group) underwent subcutaneous administration of aspirin at a dose level of (7.5mg/Kg b.w) twice daily at proestrous phase of the estrous cycle. In the control six group (6mice/ group) underwent subcutaneous administration of a placebo (distilled water) twice daily at proestrous phase of the estrous cycle
Main outcome measure(s): Uterine and ovarian morphological changes, uterine and ovarian weight changes, number of ova and serum (FSH, LH and E2) levels.
Results: There were statistically significant differences between the treated group and the control group, respectively, in the Ovarian weight (3.14 ± 0.03 versus 2.58 ± 0.06), number of ova (6.00 ± 0.37 versus 11.17 ± 0.40).
Conclusion(s): Short-term administration of a low-dose of aspirin to mice at proestrous causes the following changes: significant increase in ovarian weight with an increased congestion in the uterus and ovary. A significant decrease in ovulatory rate with no effect on serum gonadotropins and estradiol levels.
Low-dose aspirin, uterine and ovarian morphological changes, and ovulation rate.
Alternative site location: http://www.mefsjournal.org